Biggest News Aggregation in the World
📰 Complement Proteins News

Complement Proteins News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Complement Proteins. Real-time updates on events, politics, business and more.

Novartis iptacopan meets primary endpoint in new rare kidney disease trial

Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and highly statistically significant proteinuria reduction in patients with IgA nephropathy (IgAN)Ad hoc announcement pursuant to Art. 53 LRPhase III APPLAUSE-IgAN study met its pre-specified interim analysis primary endpoint, demo...
United States Shreeram Aradhye Novartis Pharmaceuticals European Medicines Agency Exchange Commission Novartis Biomedical Research

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science